FCF co-organizes, along with its associate YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which shall be held on-line on April 18th & 19th, 2022.
ACCESS CHINA Biotech Discussion board is a quarterly company entry occasion collection between China and western biopharma. It’s the simplest deal-making platform for western pharma and biotech leaders seeking to enter or broaden within the Chinese language market. The occasion will assist western biopharma corporations to effectively current their belongings on-line in entrance of 500+ biopharma corporations / 2000+ BD administrators and healthcare VCs in China. It creates invaluable BD alternatives by straight connecting and assembly with the proper companions for growth, licensing or industrial collaborations. We count on to host 100 firm displays, 10 keynote speeches, 1000+ contributors, and 250+ 1×1 conferences. Licensing exercise in China has been steadily growing over time.